Frontier Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-200,653
| Closed | -$5.53M | – | 278 |
|
|
2023
Q3 | $5.53M | Sell |
200,653
-2,000
| -1% | -$55.1K | 0.06% | 225 |
|
|
2023
Q2 | $6.09M | Sell |
202,653
-102,426
| -34% | -$3.08M | 0.06% | 226 |
|
|
2023
Q1 | $11.1M | Sell |
305,079
-350,653
| -53% | -$12.7M | 0.11% | 187 |
|
|
2022
Q4 | $23.4M | Sell |
655,732
-47,076
| -7% | -$1.68M | 0.25% | 145 |
|
|
2022
Q3 | $23.8M | Buy |
702,808
+86,433
| +14% | +$2.93M | 0.28% | 130 |
|
|
2022
Q2 | $17.8M | Sell |
616,375
-34,980
| -5% | -$1.01M | 0.21% | 157 |
|
|
2022
Q1 | $21.1M | Buy |
651,355
+33,654
| +5% | +$1.09M | 0.19% | 165 |
|
|
2021
Q4 | $18M | Buy |
617,701
+38,628
| +7% | +$1.13M | 0.14% | 182 |
|
|
2021
Q3 | $15.4M | Sell |
579,073
-237,658
| -29% | -$6.34M | 0.12% | 191 |
|
|
2021
Q2 | $25.1M | Buy |
816,731
+47,208
| +6% | +$1.45M | 0.18% | 170 |
|
|
2021
Q1 | $20.1M | Buy |
+769,523
| New | +$20.1M | 0.15% | 170 |
|